Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
about
Role and New Insights of Pirfenidone in Fibrotic DiseasesThe staphylococcal enterotoxin (SE) family: SEB and siblingsN-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetesMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisPirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burnAnti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblastsInhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04Downregulation of OPA3 is responsible for transforming growth factor-β-induced mitochondrial elongation and F-actin rearrangement in retinal pigment epithelial ARPE-19 cells.Therapeutic potential of Pirfenidone for treating equine corneal scarringDiabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantationPirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro.Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth.Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3.Immune-mediated pathology in Duchenne muscular dystrophy.Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Developing novel anti-fibrotic therapeutics to modulate post-surgical wound healing in glaucoma: big potential for small molecules.Monitoring and manipulating cellular crosstalk during kidney fibrosis inside a 3D in vitro co-culture.Drugs and Targets in Fibrosis.Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.Effects of bradykinin on TGF‑β1‑induced epithelial‑mesenchymal transition in ARPE‑19 cells.Pirfenidone inhibits post-traumatic proliferative vitreoretinopathy.Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.Essential role of connective tissue growth factor (CTGF) in transforming growth factor-β1 (TGF-β1)-induced myofibroblast transdifferentiation from Graves' orbital fibroblasts.Role of Smad3 signaling in the epithelial‑mesenchymal transition of the lens epithelium following injury.Pirfenidone suppresses TGF‑β1‑induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathwayDifferential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis
P2860
Q26774154-8206FA29-84C3-4A76-8E86-83BCC9BB0C2DQ26830220-2FA56797-A4A3-49A0-B9B1-A4796D1A4400Q27008887-A3FE075E-BF1A-466A-9815-2FB16843B36AQ27348347-838CA08A-B768-4037-8E87-285F025F7D8EQ28535107-013A6B6C-784B-4B3B-941A-9D8BB620EE5FQ34544470-4D47B015-2061-4BA4-BFA0-383DDC105DEAQ34599567-49B14B36-1E61-4DBD-A5A5-DC558B24DB36Q34713262-3A39662F-02B0-4254-B0E5-D144ECEF747FQ34964866-71673CDE-F694-44FD-B419-C64977167436Q36589609-25B2072A-5EC1-4F39-8F21-05FFC33F5DB1Q36826817-BC948E50-1426-4BBD-B98D-7BED448B0043Q37445130-673F4483-FDA0-4B26-AA96-BD7B4D2B3ACFQ37540216-9F71A745-A711-4AA0-8082-CCD246F5F432Q37676284-C6763E31-3446-4441-A4D4-1085E5771559Q38561435-2D43974F-C131-4081-8F09-989449D4CD67Q40979380-8A8342C5-CEE9-46DF-9004-4D073CA2013EQ41809872-F893195C-8846-40FF-ADA6-E9CC7BE18335Q43192239-F3FEB33D-AFE6-461E-8D0D-B12A48BBC32EQ43620784-2CB3C734-672D-4D76-A769-F535B780994EQ47119118-8C54519D-32AB-4684-8C40-AAED559EEA50Q47137290-C0F66590-9F47-442E-AE27-9630637EB0AAQ47954026-0CB6EC02-C3AB-4195-8939-D1F09901D01AQ50047787-5D1E97A5-1ECB-4725-97EE-0CFE6022345CQ50792998-DBA308F3-37D8-4F5E-A690-81D25D596F49Q53828437-1ECC5FB9-C28B-43EF-B32B-60F20E7AD0C2Q54960708-561976A2-0663-4D6F-A20B-8C3E7C6D17EBQ55479087-4FECB06F-758C-4503-81DD-A8A0D6887053Q58718304-1C30997E-E87A-439D-A7B8-0061AEFF2FB5Q58737862-0A49B82A-31F2-49FB-89D9-4E7CC8E2AF37
P2860
Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@ast
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@en
type
label
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@ast
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@en
prefLabel
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@ast
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@en
P2093
P2860
P1433
P1476
Pirfenidone inhibits transform ...... epithelial cell line ARPE-19.
@en
P2093
Chulhee Choi
Kihwang Lee
Koung Hoon Kook
Kyungsun Choi
Seung-Wook Ryu
P2860
P304
P577
2012-04-21T00:00:00Z